Generic placeholder image

Current Drug Targets - Infectious Disorders

Editor-in-Chief

ISSN (Print): 1568-0053
ISSN (Online): 1875-5852

Use of T Cell Epitopes for Vaccine Development

Author(s): H. Sbai, A. Mehta and A. S. DeGroot

Volume 1, Issue 3, 2001

Page: [303 - 313] Pages: 11

DOI: 10.2174/1568005014605955

Price: $65

Abstract

T lymphocytes play a major role in the recognition and subsequent elimination of tumors and intracellular pathogens. Induction of epitope-specific T cell responses can help in the clearance of diseases for which no conventional vaccines exist. However, the lack of simple methods to identify relevant T cell epitopes, the high mutation rate of many pathogens, and HLA polymorphism have made the development of efficient T cell epitope-based, or “epitope-driven” vaccines difficult to achieve. Our research over the past several years has applied bioinformatics tools in conjunction with T cell assays to identify naturally processed putative T cell epitopes from several pathogens. This strategy willaccelerate the development of new generation T cell epitopebased vaccines against various pathogens including viruses such as HIV and WNV, bacteria such as M.tb ., and parasites such as plasmodium. This chapter will review the use of a bioinformatics-based approach to identify putative T cell epitopes. It will summarize the current state of knowledge regarding T cell-epitope-based vaccines and discuss several ways to improve their efficacy.

Keywords: hla molecules, peptide motif, t cell epitope, bioinformatics tools, vaccine


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy